A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis (clinicaltrials.gov) - Oct 13, 2026 - P2 | N=201 | Active, not recruiting | Sponsor: Novartis Pharmaceuticals | Recruiting ➔ Active, not recruiting
Enrollment closed • Immunology • Scleroderma • Systemic Sclerosis • CRP
|